CrossrefInfokarte
Development of an adverse outcome pathway for histone deacetylase inhibition leading to axial skeletal defects via histone hyperacetylation: The potential to improve decision making in chemical safety assessments
Computational Toxicology · 2026-12 · 40 · 100463
DOI: 10.1016/j.comtox.2026.100463 ↗Abstract
Kein Abstract verfügbar.
EUVIMED